Deciphering the Role and Signaling Pathways of PKCα in Luminal A Breast Cancer Cells
Authors:
- Emilio M. Serrano-LópezESEmilio M. Serrano-López
- Teresa Coronado-ParraTCTeresa Coronado-Parra
- Consuelo Marín-VicenteCMConsuelo Marín-Vicente
- Zoltan SzallasiZSZoltan Szallasi
- Victoria Gómez-AbellánVGVictoria Gómez-Abellán
- María José López-AndreoMLMaría José López-Andreo
- Marcos GrageraMGMarcos Gragera
- Juan C. Gómez-FernándezJuan C. Gómez-Fernández
- Rubén López-NicolásRLRubén López-Nicolás
- Senena Corbalán-GarcíaSCSenena Corbalán-García
Open Access
- 14 November 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (22) , 14023
Abstract
Protein kinase C (PKC) comprises a family of highly related serine/threonine protein kinases involved in multiple signaling pathways, which control cell proliferation, survival, and differentiation. The role of PKCα in cancer has been studied for many years. However, it has been impossible to establish whether PKCα acts as an oncogene or a tumor suppressor. Here, we analyzed the importance of PKCα in cellular processes such as proliferation, migration, or apoptosis by inhibiting its gene expression in a luminal A breast cancer cell line (MCF-7). Differential expression analysis and phospho-kinase arrays of PKCα-KD vs. PKCα-WT MCF-7 cells identified an essential set of proteins and oncogenic kinases of the JAK/STAT and PI3K/AKT pathways that were down-regulated, whereas IGF1R, ERK1/2, and p53 were up-regulated. In addition, unexpected genes related to the interferon pathway appeared down-regulated, while PLC, ERBB4, or PDGFA displayed up-regulated. The integration of this information clearly showed us the usefulness of inhibiting a multifunctional kinase-like PKCα in the first step to control the tumor phenotype. Then allowing us to design a possible selection of specific inhibitors for the unexpected up-regulated pathways to further provide a second step of treatment to inhibit the proliferation and migration of MCF-7 cells. The results of this study suggest that PKCα plays an oncogenic role in this type of breast cancer model. In addition, it reveals the signaling mode of PKCα at both gene expression and kinase activation. In this way, a wide range of proteins can implement a new strategy to fine-tune the control of crucial functions in these cells and pave the way for designing targeted cancer therapies.Keywords
Funding Information
- Fundación Séneca Región de Murcia (20885/PI/18, BFU2017-87222-P)
- MICINN, Spain-FEDER (20885/PI/18, BFU2017-87222-P)
This publication has 110 references indexed in Scilit:
- p85β phosphoinositide 3-kinase subunit regulates tumor progressionProceedings of the National Academy of Sciences, 2012
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics DataCancer Discovery, 2012
- Feedback regulation of EGFR signalling: decision making by early and delayed loopsNature Reviews Molecular Cell Biology, 2011
- Keratins in health and cancer: more than mere epithelial cell markersOncogene, 2010
- The Phosphoinositide 3-Kinase Regulatory Subunit p85α Can Exert Tumor Suppressor Properties through Negative Regulation of Growth Factor SignalingCancer Research, 2010
- ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networksBioinformatics, 2009
- p53 stabilization in response to DNA damage requires Akt/PKB and DNA-PKProceedings of the National Academy of Sciences, 2008
- Diacylglycerol Is Required for the Formation of COPI Vesicles in the Golgi-to-ER Transport PathwayMolecular Biology of the Cell, 2007
- Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistanceBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2007
- Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction NetworksGenome Research, 2003